Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1

Archives of Dermatology

Volumn 145, Issue 8, 2009, Pages 883-887

  Nunley, Kara S ^a   Gao, Feng ^a   Albers, Anne C ^a   Bayliss, Susan J ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE DISEASE; CAFE AU LAIT SPOT; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFANT; MACROCEPHALY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NERVE GLIOMA; PHEOCHROMOCYTOMA; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE;

CAFE-AU-LAIT SPOTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEUROFIBROMATOSIS 1;

EID: 68949148998     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.169     Document Type: Article

References (19)

1. Ward BA, Gutmann DH. Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol. 2005;32(4):221-228.
2. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis: Bethesda, Md, USA, July 13-15, 1987. Neurofibromatosis. 1988;1(3):172-178.
3. Tonsgard JH. Clinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol. 2006;13(1):2-7.
4. North K. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol. 1993;8(4):395-402.
5. Boulanger JM, Larbrisseau A. Neurofibromatosis type 1 in a pediatric population: Ste-Justine's experience. Can J Neurol Sci. 2005;32(2):225-231.
6. Whitehouse D. Diagnostic value of the cafe-au-lait spot in children. Arch Dis Child. 1966;41(217):316-319.
7. Alper J, Holmes LB, Mihm MC Jr. Birthmarks with serious medical significance: nevocullular nevi, sebaceous nevi, and multiple cafe au lait spots. J Pediatr. 1979;95(5, pt 1):696-700.
8. Burwell RG, James NJ, Johnston DI. Cafe-au-lait spots in schoolchildren. Arch Dis Child. 1982;57(8):631-632.
9. Landau M, Krafchik BR. The diagnostic value of cafe-au-lait macules. J Am Acad Dermatol. 1999;40(6, pt 1):877-892.
10. Arnsmeier SL, Riccardi VM, Paller AS. Familial multiple cafe au lait spots. Arch Dermatol. 1994;130(11):1425-1426.
11. Brems H, Chmara M, Sahbatou M, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007;39(9):1120-1126.
12. Charrow J, Listernick R, Ward K. Autosomal dominant multiple cafe-au-lait spots and neurofibromatosis-1: evidence of non-linkage. Am J Med Genet. 1993;45(5):606-608.
13. Hoo JJ, Shrimpton AE. Familial hyper- and hypopigmentation with age-related pattern change. Am J Med Genet A. 2005;132A(2):215-218.
14. Korf BR. Diagnostic outcome in children with multiple cafe au lait spots. Pediatrics. 1992;90(6):924-927.
15. Fois A, Calistri L, Balestri P, et al. Relationship between cafe-au-lait spots as the only symptom and peripheral neurofibromatosis (NF1): a follow-up study. Eur J Pediatr. 1993;152(6):500-504.
16. Tekin M, Bodurtha JN, Riccardi VM. Cafe au lait spots: the pediatrician's perspective. Pediatr Rev. 2001;22(3):82-90.
17. Hersh JH; American Academy of Pediatrics Committee on Genetics. Health supervision for children with neurofibromatosis. Pediatrics. 2008;121(3):633-642.
18. Obringer AC, Meadows AT, Zackai EH. The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am J Dis Child. 1989;143(6):717-719.
19. Messiaen LM, Callens T, Mortier G, et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15(6):541-555.